Normax Biomed is an mRNA Vaccine research and development and manufacturing company.
Normax Biomed has raised $301.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2022.
Normax Biomed's investors include The Global Emerging Markets Group.
Normax Biomed is headquartered in Cork, Ireland.
Normax Biomed is an mRNA Vaccine research and development and manufacturing company.
Normax Biomed is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Normax Biomed — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/normax-biomed. Accessed August 14, 2026.
VCBacked. (2022). Normax Biomed — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/normax-biomed
{{cite web |title=Normax Biomed — Funding & Investors |url=https://www.vcbacked.co/company/normax-biomed |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated